Citation: | SUN Juan, LIU Jianzhou, WEN Jin, LI Hanzhong, JI Zhigang, DONG Dexin, YE Zixing, MIAO Qi, TONG Anli, HUANG Yuguang, LONG Yun. Carotid Body Tumor, Cardiac Paraganglioma, Adrenal Pheochromocytoma: A Contest with Hypercatecholamineemia[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 1022-1029. DOI: 10.12290/xhyxzz.2021-0134 |
[1] |
嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36: 737-750.
|
[2] |
Beard CM, Sheps SG, Kurland LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979[J]. Mayo Clin Proc, 1983, 58: 802-804. http://www.ncbi.nlm.nih.gov/pubmed/6645626
|
[3] |
McNeil AR, Blok BH, Koelmeyer TD, et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland[J]. Aust N Z J Med, 2000, 30: 648-652. DOI: 10.1111/j.1445-5994.2000.tb04358.x
|
[4] |
Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series[J]. Mayo Clin Proc, 1981, 56: 354-360. http://europepmc.org/abstract/med/6453259
|
[5] |
Scoazec JY, Couvelard A, Réseau TENpath. Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future[J]. Ann Pathol, 2017, 37: 444-456. DOI: 10.1016/j.annpat.2017.10.003
|
[6] |
Abdelhady K, Durgam S, Orza D, et al. Left Atrial and Carotid Body Paraganglioma[J]. Ann Thorac Surg, 2017, 103: e323-e325. DOI: 10.1016/j.athoracsur.2016.09.062
|
[7] |
Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients[J]. J Clin Endocrinol Metab, 2001, 86: 5210-5216. DOI: 10.1210/jcem.86.11.8034
|
[8] |
Al-Harthy M, Al-Harthy S, Al-Otieschan A, et al. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas[J]. Endocr Pract, 2009, 15: 194-202. DOI: 10.4158/EP.15.3.194
|
[9] |
Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification[J]. Endocr Pathol, 2012, 23: 4-14. DOI: 10.1007/s12022-011-9188-1
|
[10] |
Kimura N, Watanabe T, Noshiro T, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors[J]. Endocr Pathol, 2005, 16: 23-32. DOI: 10.1385/EP:16:1:023
|
[11] |
Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases[J]. Am J Surg Pathol, 2002, 26: 551-566. DOI: 10.1097/00000478-200205000-00002
|
[12] |
Strong VE, Kennedy T, Al-Ahmadie H, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis[J]. Surgery, 2008, 143: 759-768. DOI: 10.1016/j.surg.2008.02.007
|
[13] |
de Wailly P, Oragano L, Radé F, et al. Malignant pheochromocytoma: new malignancy criteria[J]. Langenbecks Arch Surg, 2012, 397: 239-246. DOI: 10.1007/s00423-011-0850-3
|
[14] |
Agarwal A, Mehrotra PK, Jain M, et al. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?[J]. World J Surg, 2010, 34: 3022-3028. DOI: 10.1007/s00268-010-0744-5
|
[15] |
Chen H, Sippel RS, O'Dorisio MS, et al. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer[J]. Pancreas, 2010, 39: 775-783. DOI: 10.1097/MPA.0b013e3181ebb4f0
|
[16] |
Boedeker CC, Neumann HP, Offergeld C, et al. Clinical features of paraganglioma syndromes[J]. Skull Base, 2009, 19: 17-25. DOI: 10.1055/s-0028-1103123
|
[17] |
Shen WT, Grogan R, Vriens M, et al. One Hundred Two Patients With Pheochromocytoma Treated at a Single Institution Since the Introduction of Laparoscopic Adrenalectomy[J]. Arch Surg, 2010, 145: 893-897. DOI: 10.1001/archsurg.2010.159
|
[18] |
Huang KH, Chung SD, Chen SC, et al. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute[J]. Int J Urol, 2007, 14: 181-185. DOI: 10.1111/j.1442-2042.2007.01687.x
|
[19] |
Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management[J]. Pediatr Nephrol, 2020, 35: 581-594. DOI: 10.1007/s00467-018-4181-2
|
[20] |
Bholah R, Bunchman TE. Review of Pediatric Pheochromocytoma and Paraganglioma[J]. Front Pediatr, 2017, 5: 155. DOI: 10.3389/fped.2017.00155
|
[1] | WANG Yajuan, WANG Yuan, REN Xinyu. Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 616-623. DOI: 10.12290/xhyxzz.2023-0454 |
[2] | ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180 |
[3] | Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015 |
[4] | Ying JIANG, Xiao-yan CHANG, Jie CHEN. Clinicopathological Features of Fibromatosis of the Breast[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(6): 442-445. DOI: 10.3969/j.issn.1674-9081.2015.06.009 |
[5] | Xiao-hua SHI, Sha-fei WU, Qing LING, Zhen HUO, Zhi-yong LIANG. Clinicopathological Features and Immunohistochemical Phenotypes of Adenoid Cystic Carcinoma of the Uterine Cervix[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 197-201. DOI: 10.3969/j.issn.1674-9081.2015.03.007 |
[6] | Jing ZHANG, Jie GAO, Sha-fei WU, Tao LU, Zhi-yong LIANG. Clinicopathological Features and Epidermal Growth Factor Receptor Gene Status of Adrenocortical Oncocytic Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 191-196. DOI: 10.3969/j.issn.1674-9081.2015.03.006 |
[8] | Jie LIU, Tao ZHOU, Kai FANG, Dong-lai MA, Yue-hua LIU. Clinical and Pathological Characteristics of Patients with Lipodystrophia Centifugalis Abdominalis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 423-426. DOI: 10.3969/j.issn.1674-9081.2012.04.014 |
[9] | Xiao-feng JIN, Xing-ming CHEN, Wu-yi LI, Pei-hong PENG, Hong JIANG, Xiao-li ZHU, Ke-li CAO, Bao-quan ZHANG, Lian-shan ZHANG, Zhi-qiang GAO. Clinical and Pathological Characteristics and Treatment Outcome of Sarcoma of the Larynx[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(2): 170-174. DOI: 10.3969/j.issn.1674-9081.2012.02.009 |
[10] | Li GE, Rui-e FENG, Xin-lun TIAN, Ju-hong SHI, Tao LIU, Zuo-jun XU, Wen-bing XU, Wei SONG, Hong-rui LIU, Yuan-jue ZHU. Clinical and Pathological Features of Pulmonary Intravascular Lymphoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 30-35. DOI: 10.3969/j.issn.1674-9081.2012.01.008 |